Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H, Dejima T, Tamura K, Uneda K, Azuma K, Maeda A, Ohsawa M, Kanaoka T, Azushima K, Kobayashi R, Matsuda M, Yamashita A, Umemura S. Wakui H, et al. Among authors: uneda k. Cardiovasc Res. 2013 Dec 1;100(3):511-9. doi: 10.1093/cvr/cvt225. Epub 2013 Nov 4. Cardiovasc Res. 2013. PMID: 24189624
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.
Kanaoka T, Tamura K, Ohsawa M, Wakui H, Maeda A, Dejima T, Azushima K, Haku S, Mitsuhashi H, Yanagi M, Oshikawa J, Uneda K, Aoki K, Fujikawa T, Toya Y, Uchino K, Umemura S. Kanaoka T, et al. Among authors: uneda k. J Clin Hypertens (Greenwich). 2012 Aug;14(8):522-9. doi: 10.1111/j.1751-7176.2012.00640.x. Epub 2012 May 3. J Clin Hypertens (Greenwich). 2012. PMID: 22863160 Free PMC article. Clinical Trial.
An increase in perfusion pressure and activation of the renin-angiotensin system in the pathogenesis of hypertension and injury: strain vessels and the cerebrovascular-renal connection.
Tamura K, Maeda A, Uneda K, Wakui H, Dejima T, Mitsuhashi H, Yamaguchi S, Tsurumi-Ikeya Y, Tokita Y, Umemura S. Tamura K, et al. Among authors: uneda k. Hypertens Res. 2012 Oct;35(10):972-4. doi: 10.1038/hr.2012.108. Epub 2012 Aug 23. Hypertens Res. 2012. PMID: 22914554 No abstract available.
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A, Umemura S. Tamura K, et al. Among authors: uneda k. Curr Pharm Des. 2013;19(17):3043-8. doi: 10.2174/1381612811319170010. Curr Pharm Des. 2013. PMID: 23176217 Review.
Aliskiren induced remarkable hypertriglyceridemia.
Azushima K, Tamura K, Wakui H, Maeda A, Kanaoka T, Ohsawa M, Haku S, Uneda K, Toya Y, Umemura S. Azushima K, et al. Among authors: uneda k. Intern Med. 2012;51(24):3387-9. doi: 10.2169/internalmedicine.51.8567. Epub 2012 Dec 15. Intern Med. 2012. PMID: 23257525 Free article.
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.
Wakui H, Tamura K, Masuda S, Tsurumi-Ikeya Y, Fujita M, Maeda A, Ohsawa M, Azushima K, Uneda K, Matsuda M, Kitamura K, Uchida S, Toya Y, Kobori H, Nagahama K, Yamashita A, Umemura S. Wakui H, et al. Among authors: uneda k. Hypertension. 2013 Jun;61(6):1203-10. doi: 10.1161/HYPERTENSIONAHA.111.00572. Epub 2013 Mar 25. Hypertension. 2013. PMID: 23529167 Free PMC article.
Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.
Tamura K, Tsurumi-Ikeya Y, Wakui H, Maeda A, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Haku S, Azuma K, Mitsuhashi H, Tamura N, Toya Y, Tokita Y, Kokuho T, Umemura S. Tamura K, et al. Among authors: uneda k. Ther Apher Dial. 2013 Apr;17(2):185-92. doi: 10.1111/j.1744-9987.2012.01149.x. Epub 2012 Dec 7. Ther Apher Dial. 2013. PMID: 23551675 Review.
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S. Ohsawa M, et al. Among authors: uneda k. Int J Mol Sci. 2013 Jul 24;14(8):15361-75. doi: 10.3390/ijms140815361. Int J Mol Sci. 2013. PMID: 23887656 Free PMC article. Clinical Trial.
59 results